Shandong Haishan Pharmaceutical Co. Ltd.

The main purpose of the study was to observe the pharmacokinetic process of cefixime in vivo, estimate the corresponding pharmacokinetic parameters, and evaluate the bioequivalence of the test preparation cefixime tablets and the reference preparation cefixime tablets (Suprax) in healthy subjects after oral administration of a single dose of cefixime tablets in the fasting state. The secondary purpose of the study was to observe the safety of the test preparation cefixime tablets and the reference preparation cefixime tablets (Suprax) in healthy subjects.

The main purpose of the study was to observe the in vivo kinetics of cefdinir after a single oral dose of cefdinir granules was administered to healthy subjects in the fasting and postprandial states, estimate the corresponding pharmacokinetic parameters, and conduct bioequivalence evaluation. The secondary purpose of the study was to observe the safety of the test preparation cefdinir granules and the reference preparation cefdinir granules (Cefzon) in healthy subjects.

The main purpose of the study: After a single dose of cefixime tablets was taken orally in healthy subjects in the fasting and postprandial state, the pharmacokinetic process of cefixime in vivo was observed, the corresponding pharmacokinetic parameters were estimated, and bioequivalence evaluation was performed. The secondary purpose of the study: To observe the safety of the test preparation cefixime tablets and the reference preparation cefixime tablets (Suprax) in healthy subjects.